A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III)-Reference-Cited by-同舟云学术

A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III)

Published:2017-05-09 Issue:6 Volume:4 Page:360-368
ISSN:2328-9503
Container-title:Annals of Clinical and Translational Neurology
language:en
Short-container-title:Ann Clin Transl Neurol

Author:

Biglan Kevin M.¹²,Oakes David³,Lang Anthony E.⁴,Hauser Robert A.⁵,Hodgeman Karen²,Greco Brittany²,Lowell Jillian¹,Rockhill Rebecca²,Shoulson Ira⁶,Venuto Charles²,Young Diony⁷,Simuni Tanya⁸,

Affiliation:

1. Department of Neurology; University of Rochester; Rochester New York

2. Center for Human Experimental Therapeutics; University of Rochester; Rochester New York

3. Department of Biostatistics and Computational Biology; University of Rochester; Rochester New York

4. Morton and Gloria Shulman Movement Disorder Unit & Edmond J. Safra Parkinson Disease Program; Neurology Division; Department of Medicine; Toronto Western Hospital; University Health Network, University of Toronto; Toronto Ontario Canada

5. Department of Neurology; University of South Florida; Tampa Florida

6. Department of Neurology and Program for Regulatory Science & Medicine; Georgetown University; Washington District of Columbia

7. Parkinson Disease Foundation; New York City New York

8. Department of Neurology; Northwestern University; Chicago Illinois

Funder

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Clinical Neurology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/acn3.412/fullpdf